Jasper Therapeutics Inc (NASDAQ: JSPR) is 176.30% higher on its value in year-to-date trading and has touched a low of $4.00 and a high of $31.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The JSPR stock was last observed hovering at around $20.09 in the last trading session, with the day’s gains setting it 1.71%.
Currently trading at $21.80, the stock is 20.15% and 10.03% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 8.51% at the moment leaves the stock 20.30% off its SMA200. JSPR registered 75.81% gain for a year compared to 6-month loss of -1.27%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 25.72% gain in the last 1 month and extending the period to 3 months gives it a -16.02%, and is 13.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.91% over the week and 7.55% over the month.
Jasper Therapeutics Inc (JSPR) has around 45 employees, a market worth around $329.40M and $0.00M in sales. Distance from 52-week low is 445.00% and -29.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-61.45%).
The EPS is expected to grow by 33.31% this year.
Jasper Therapeutics Inc (JSPR) Top Institutional Holders
93.0 institutions hold shares in Jasper Therapeutics Inc (JSPR), with institutional investors hold 103.79% of the company’s shares. The shares outstanding are 15.11M, and float is at 11.57M with Short Float at 15.88%. Institutions hold 98.65% of the Float.
Jasper Therapeutics Inc (JSPR) Insider Activity
The most recent transaction is an insider sale by Mahal Jeetinder Singh,the company’sChief Operating Officer. SEC filings show that Mahal Jeetinder Singh sold 900 shares of the company’s common stock on Jun 12 ’24 at a price of $24.16 per share for a total of $21740.0. Following the sale, the insider now owns 25009.0 shares.
Jasper Therapeutics Inc disclosed in a document filed with the SEC on Mar 12 ’24 that Mahal Jeetinder Singh (Chief Operating Officer) sold a total of 900 shares of the company’s common stock. The trade occurred on Mar 12 ’24 and was made at $26.44 per share for $23792.0. Following the transaction, the insider now directly holds 25009.0 shares of the JSPR stock.
Still, SEC filings show that on Feb 08 ’24, Carlyle Group Inc. (Former 10% Owner) acquired 190,000 shares at an average price of $12.95 for $2.46 million. The insider now directly holds 1,066,189 shares of Jasper Therapeutics Inc (JSPR).
